New Formulation of Rotarix Removes the Need for Reconstitution

The FDA has approved an oral-dosing applicator-only presentation of Rotarix (live oral rotavirus vaccine) to prevent gastroenteritis in infants.

Related Keywords

,Clinical Affairs ,Glaxosmithkline ,Drug Administration ,Temi Folaranmi ,Vice President ,